| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.5B | $2.8B | $1.4B | $3.7B | $1.0B | $1.1B | $-0.5B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.2B | $1.2B | $0.5B | $0.7B | $0.2B | $0.1B | $0.0B |
| EPS (Basic) | — | $2.10 | $13.00 | $4.58 | $-0.07 | $2.41 | $0.59 | $0.41 |
| EPS (Diluted) | — | $2.06 | $12.86 | $4.55 | $-0.07 | $2.40 | $0.59 | $0.41 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $121.2B | $79.9B | $73.9B | $78.3B | $71.4B | $69.7B | $61.6B | $62.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $11.3B | $9.8B | $1.9B | $4.5B | $9.1B | $2.3B | $0.3B | $1.4B |
| Total Liabilities | $111.2B | $76.9B | $70.7B | $72.0B | $64.8B | $65.1B | $59.2B | $59.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | $3.0B | $3.2B | $6.3B | $6.6B | $4.6B | $2.4B | $2.9B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $3.9B | $2.0B | $4.2B | $1.3B | $3.4B | $0.0B | $1.9B |
| Investing Cash Flow | $2.5B | $4.5B | $-2.5B | $-6.2B | $5.1B | $-3.1B | $-2.4B | $-2.6B |
| Capital Expenditures | — | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $3.1B | $-0.6B | $-2.2B | $-2.6B | $0.4B | $1.7B | $1.3B | $1.3B |